{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:03:34Z","timestamp":1757621014916,"version":"3.44.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RAIAD"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>It is well known that acute or chronic kidney injury could be due to free\nradicals and pro-oxidants. This investigation aimed to monitor tacrolimus or cyclosporine blood\ntrough levels and anti-oxidant capacity after kidney transplantation. Methods: There was no intervention\nin the routine management of transplant recipients. The sample size (n=70) included\nhealthy individuals and kidney-transplanted recipients (n=25 on tacrolimus and n=10 on cyclosporine).\nThe study population was matched for age. The attained information was examined by\nusing the Statistical Package (SPSS Inc, Chicago, IL, USA). The significance level was considered\nas P \u2264 0.05.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>In healthy individuals, the mean \u00b1 SD for the capacity of antioxidants was 91.9 \u00b1 16.6\n(u\/ml), which was significantly higher when compared to the mean value of 28.5 \u00b1 22.6 (u\/ml)\nversus 24.7 \u00b1 25.5 (u\/ml), kidney recipients with tacrolimus versus cyclosporine (P \u2264 0.04) as\nimmunosuppressive drugs. The mean value of tacrolimus levels was 14.6 \u00b1 6.4 (ng\/ml). The\ncorrelation between tacrolimus and cyclosporine trough levels and anti-oxidant capacity was\n0.19 (P \u2264 0.14). There were no significant differences regarding age in cases and controls (P \u2264\n42).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study showed that the capacity of anti-oxidants in kidney transplant recipients,\nthose on tacrolimus or cyclosporine, might be lower than in healthy individuals. Subsequent\ninvestigations are recommended to delve into the therapeutic consequences of the influence\nof antioxidant therapies on the clinical outcomes of transplanted recipients.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0127722708319486241202113259","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T05:53:47Z","timestamp":1733896427000},"page":"374-379","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monitoring Tacrolimus and Cyclosporine Blood Trough Levels and the Capacity of Anti-oxidant after Kidney Transplantation: A Patent Perspective"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3994-0211","authenticated-orcid":true,"given":"Zahra","family":"Tolou-Ghamari","sequence":"first","affiliation":[{"name":"Nutrition and Food Security Research Center, Deputy of Research and Technology, Isfahan University of Medical Sciences,\nIsfahan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Recent Advances in Inflammation &amp; Allergy Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0127722708319486241202113259","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/237002\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0127722708319486241202113259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:20:24Z","timestamp":1757330424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/237002\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0127722708319486241202113259","relation":{},"ISSN":["2772-2708"],"issn-type":[{"type":"print","value":"2772-2708"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}